$HALO Company News S&P 500 violates major support 11:20

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2015 at 12:18 PM

$HALO Company News

S&P 500 violates major support 11:20 a.m. Jan. 7, 2015 - Michael Ashbaugh
Fossil Group swings higher on earnings beat, license renewal 6:30 a.m. Nov. 12, 2014 - Wallace Witkowski
Amazon gains on June event; PVH sinks on results 2:36 p.m. June 5, 2014 - Sue Chang
Stock futures rise after ECB moves, claims report 8:00 a.m. June 5, 2014 - Barbara Kollmeyer
ECB, jobs report could finally ignite the stock-market powder keg 7:46 a.m. June 5, 2014 - Shawn Langlois
PVH falls, Halozyme, Five Below, gain after hours 3:51 p.m. June 4, 2014 - Myra P. Saefong
Rackspace shares surge after hours on earnings 5:10 p.m. May 12, 2014 - Wallace Witkowski
Halozyme temporarily halts dosing in cancer study 8:27 a.m. April 4, 2014 - MarketWatch.com
A Morgan Stanley buy, Alcoa's report and the streaker opens up 7:18 a.m. Oct. 8, 2013 - Shawn Langlois
Halozyme shares jump on Roche $10 million milestone payment 11:40 a.m. Sept. 27, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
European regulators smile on small biotech Halozyme, and shares soar 5:22 p.m. June 28, 2013 - Russ Britt
Little-noticed firm makes a splash with pancreatic cancer treatment 1:25 p.m. May 16, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 5:49 a.m. March 25, 2013 - Shawn Langlois
Synageva director bought shares for trust 1:41 p.m. Jan. 17, 2013 - Insider Monkey
Friday’s biggest gaining and declining stocks 3:51 p.m. Dec. 21, 2012 - Matt Andrejczak
ViroPharma gets okay to test reformulated Cinryze 12:09 p.m. Sept. 21, 2012 - MarketWatch.com
Halozyme soars 27% on Cinryze drug update 10:51 a.m. Sept. 21, 2012 - Val Brickates Kennedy
FDA lifts temporary hold on ViroPharma treatment 7:30 a.m. Sept. 21, 2012 - MarketWatch.com

'Mad Money' Lightning Round: Be Careful Investing in Google 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 8:19 p.m. Jan. 9, 2015 - TheStreet.com
Today's Perilous Reversal Stock: Halozyme Therapeutics (HALO) 9:49 a.m. Jan. 9, 2015 - TheStreet.com
Halozyme up on upgrade 12:14 p.m. Jan. 8, 2015 - Seeking Alpha
Barbarian At The Gate: Halozyme Therapeutics (HALO) 9:58 a.m. Jan. 8, 2015 - TheStreet.com
Benzinga's Volume Movers 9:33 a.m. Jan. 8, 2015 - benzinga.com
UPDATE: MLV & Co Raises PT On Halozyme Therapeutics On Promising Start To 2015 8:36 a.m. Jan. 8, 2015 - benzinga.com
Hottest Healthcare Stocks Now – NBIX IPXL HALO VRX 5:45 a.m. Jan. 8, 2015 - InvestorPlace.com
Halozyme Closes In On A Breakout: A Technical Analysis 1:31 p.m. Jan. 7, 2015 - benzinga.com
Hottest Healthcare Stocks Now – HALO NBIX AMAG ENDP 5:45 a.m. Jan. 7, 2015 - InvestorPlace.com
What Investors Are Looking for After Seeing Unusual Options Activity In Halozyme 11:15 a.m. Jan. 6, 2015 - benzinga.com
First Week Of February 2015 Options Trading For Halozyme Therapeutics 10:59 a.m. Dec. 30, 2014 - TheStreet.com
13 Analyst Stocks at $10 and Under With Huge Implied Upside 8:41 a.m. Dec. 27, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – INCY ALXN HALO VRTX 12:45 p.m. Dec. 26, 2014 - InvestorPlace.com
Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More 8:27 a.m. Dec. 24, 2014 - 247WallSt.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
MLV & Co Initiates Halozyme Therapeutics With Buy 6:11 a.m. Dec. 24, 2014 - benzinga.com
Halozyme's PEGPH20 tagged an Orphan Drug in Europe 10:31 a.m. Dec. 19, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com
Halozyme Up on Collaboration and Licensing Deal with J&J - Analyst Blog 6:48 p.m. Dec. 18, 2014 - Zacks.com

Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver 9:31 a.m. Jan. 8, 2015 - PR Newswire - PRF
Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony 7:30 a.m. Jan. 8, 2015 - PR Newswire - PRF
Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference 4:30 p.m. Jan. 6, 2015 - PR Newswire - PRF
Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer 8:30 a.m. Jan. 5, 2015 - PR Newswire - PRF
Halozyme Therapeutics To Host Analyst And Investor Meeting 9:00 a.m. Dec. 30, 2014 - PR Newswire - PRF
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325414 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Halozyme Receives European Orphan Drug Designation For PEGylated Recombinant Human Hyaluronidase PH20 For Pancreatic Cancer 8:30 a.m. Dec. 19, 2014 - PR Newswire - PRF
Deal Street: Analyst Coverage on Visteon, Halozyme, Coca-Cola, Groupon and Barrick Gold 9:30 a.m. Dec. 18, 2014 - PR Newswire - PRF
Halozyme Therapeutics Enters A Global Collaboration With Janssen To Develop And Commercialize Subcutaneous Products Using ENHANZE™ Technology 9:00 a.m. Dec. 17, 2014 - PR Newswire - PRF
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Halozyme Announces Presentations Of Preclinical Data At The San Antonio Breast Cancer Symposium Annual Meeting 8:00 a.m. Dec. 12, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The 25th Annual Oppenheimer Healthcare Conference 4:15 p.m. Dec. 3, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 4:15 p.m. Nov. 25, 2014 - PR Newswire - PRF
Halozyme Reports Third Quarter 2014 Financial Results 4:05 p.m. Nov. 10, 2014 - PR Newswire - PRF
Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference 4:15 p.m. Nov. 5, 2014 - PR Newswire - PRF
Halozyme to Host Third Quarter 2014 Financial Results Conference Call 4:15 p.m. Nov. 3, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Baxter Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency 8:02 a.m. Oct. 20, 2014 - BusinessWire - BZX
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 7:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Halozyme Announces Podium Presentation On PEGPH20 At The New York Academy Of Sciences 8:00 a.m. Oct. 9, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...